CTVA vs ICL: Corteva and ICL Israel Chemicals compared
The short version
From the latest prices and each company's SEC filings. Who's ahead on each measure, not which to buy.
- Corteva is the larger company, worth $8.7B, about 1.4 times ICL Israel Chemicals.
- ICL Israel Chemicals grew revenue faster over the last year (+4.6% vs -1.2%).
- On earnings, Corteva is the cheaper stock (7.1x vs 27.9x).
Side by side
The stronger figure is shaded where higher (or, for valuation multiples, lower) reads as better. How the implied growth works.
| Measure | CTVA | ICL |
|---|---|---|
| Market cap | $8.7B | $6.1B |
| Share price | $13.24 | $5.02 |
| Revenue (last fiscal year) | $17.4B | $7.2B |
| Free cash flow (last fiscal year) | $2.8B | — |
| Revenue growth, last year | -1.2% | +4.6% |
| Revenue growth per year, last 5 fiscal years | +2.7% | +0.7% |
| Operating margin | — | 8.1% |
| Net margin | 5.7% | 3.2% |
| Return on equity | 4.0% | 3.8% |
| P/E (trailing) | 7.06x | 27.9x |
| Price / free cash flow | 3.10x | 47.1x |
| EV / EBITDA | 3.13x | 6.98x |
| FCF growth the price implies | -21.6% | — |
| Dividend yield | 5.4% | 4.0% |
| Debt / equity | 0.65x | 1.03x |
| Fundamental grade | C | D |
| Superinvestors holding it | 8 | 1 |
| Insider purchases, last 12 months | 2 | 0 |
Results from SEC filings
Revenue and free cash flow by fiscal year, from each company's 10-K filings.
Corteva
| Year | Revenue | Free cash flow | Op. margin |
|---|---|---|---|
| 2021 | $15.7B | $2.2B | — |
| 2022 | $17.5B | $267M | — |
| 2023 | $17.2B | $1.2B | — |
| 2024 | $16.9B | $1.5B | — |
| 2025 | $17.4B | $2.8B | — |
ICL Israel Chemicals
| Year | Revenue | Free cash flow | Op. margin |
|---|---|---|---|
| 2021 | $7.0B | — | 17.4% |
| 2022 | $10.0B | — | 35.1% |
| 2023 | $7.5B | — | 15.1% |
| 2024 | $6.8B | — | 11.3% |
| 2025 | $7.2B | — | 8.1% |
Where the revenue comes from
Corteva · by segments, 2025
Seed$9.9B57%
Crop Protection$7.5B43%
ICL Israel Chemicals · by segments, 2025
Phosphate Solutions$2.3B31%
Growing Solutions$2.1B27%
Potash$1.7B23%
Industrial Products$1.3B17%
Other Activities$183M2%
Compare them in fullFifteen years of statements, quarterly results, DCF and IRR models, and any number of peers side by side.
Open CTVA in InvestinglyQuestions
Which is bigger, Corteva or ICL Israel Chemicals?
Corteva (CTVA), at $8.7B against $6.1B.
Is CTVA or ICL cheaper?
By trailing P/E, Corteva (7.06x) is cheaper than ICL Israel Chemicals (27.9x). A lower multiple can also mean the market expects less growth.
Which grows faster, CTVA or ICL?
ICL Israel Chemicals: revenue grew +4.6% over the last year, against -1.2%.
Prices and ratios as of the last daily update; statements from SEC filings. Information only, not investment advice.